IP Verse

Isoxazoline Compositions And Their Use As Antiparasitics For Felines - EP3473101

The patent EP3473101 was granted to Intervet on May 12, 2021. The application was originally filed on Aug 15, 2008 under application number EP18205103A. The patent is currently recorded with a legal status of "Revoked".

EP3473101

INTERVET
Application Number
EP18205103A
Filing Date
Aug 15, 2008
Status
Revoked
Oct 11, 2024
Grant Date
May 12, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

CEVA SANTE ANIMALEFeb 11, 2022CABINET BECKER ET ASSOCIESADMISSIBLE
VIRBACFeb 11, 2022GEVERS & ORESADMISSIBLE

Patent Citations (47) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONWO2008JP54096-
DESCRIPTIONEP0539588
DESCRIPTIONEP1932836
DESCRIPTIONJP2007308471
DESCRIPTIONJP2008133242
DESCRIPTIONUS2005182059
DESCRIPTIONUS2006128779
DESCRIPTIONUS2006281695
DESCRIPTIONUS2007066617
DESCRIPTIONUS3950360
DESCRIPTIONUS3984564
DESCRIPTIONUS4199569
DESCRIPTIONUS4310519
DESCRIPTIONUS4916154
DESCRIPTIONUS5089480
DESCRIPTIONUS5288710
DESCRIPTIONUS5399582
DESCRIPTIONUS5399717
DESCRIPTIONUS5595991
DESCRIPTIONUS5834260
DESCRIPTIONUS5945317
DESCRIPTIONUS5962499
DESCRIPTIONUS6221894
DESCRIPTIONUS7312248
DESCRIPTIONUS7361689
DESCRIPTIONWO2005044784
DESCRIPTIONWO2005085216
DESCRIPTIONWO2006050887
DESCRIPTIONWO2007026965
DESCRIPTIONWO2007115643
DESCRIPTIONWO9629073
OPPOSITIONEP1066854
OPPOSITIONEP1671941
OPPOSITIONEP1672941
OPPOSITIONEP1731512
OPPOSITIONUS2007066617
OPPOSITIONWO2007018659
OPPOSITIONWO2007067470
OPPOSITIONWO2007070606
OPPOSITIONWO2007075459
OPPOSITIONWO2007079162
OPPOSITIONWO2008055881
OPPOSITIONWO2009003075
OPPOSITIONWO9802042
OPPOSITIONWO9811780
SEARCHUS2007066617
SEARCHWO2009003075

Non-Patent Literature (NPL) Citations (19) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- KAMINSKY, R. et al., "A new class of anthelmintics effective against drug-resistant nematodes", Nature, (20080313), vol. 452, doi:doi:10.1038/nature06722, pages 176 - 180, XP055162540
EXAMINATION- FISARA ET AL., "Efficacy of a spot-on combination of fluralaner plus moxidectin (Bravecto Plus) in cats following repeated experimental challenge with a field isolate of Ctenocephalides felis", PARASITES VECTORS, (2019), vol. 12, no. 259-
OPPOSITION- Anonymous, "Advantage® DUO", Freedom of Information Summary NADA 141-208, (20020927), XP055896864-
OPPOSITION- Anonymous, "Advantage Multi for dogs. Imidacloprid + Moxidectin", Freedom of Information Summary NADA 141-251, (20061220), XP055896920-
OPPOSITION- Anonymous, "HEARTGARD-30®", Freedom of Information Summary - NADA 138-412, (19870302), pages 1 - 20, Freedom of Information Summary - NADA 138-412, (20220228), XP055896027-
OPPOSITION- Anonymous, "HEARTGARD™ for Cats", Freedom of Information Summary - NADA 141-078, (19961223), pages 1 - 21, Freedom of Information Summary - NADA 141-078, (20220228), XP055896033-
OPPOSITION- Anonymous, "Interceptor®", Freedom of Information Summary - NADA 140-915, (19960909), pages 1 - 4, Freedom of Information Summary - NADA 140-915, (20220228), XP055896029-
OPPOSITION- Anonymous, "Proheart for dogs", Freedom of Information Summary - NADA 141-051, (19970527), pages 1 - 17, URL: https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/3629, XP055896819-
OPPOSITION- Anonymous, "REVOLUTION®", Freedom of Information Summary - NADA 141-152, (20000613), Freedom of Information Summary - NADA 141-152, (20220228), XP055896043-
OPPOSITION- Anonymous, "SENTINEL* (milbemycin oxime/Iufenuron) Flavor Tabs* and CAPSTAR* (nitenpyram) Tablets", Freedom of Information Summary NADA 141-204, (20030611), XP055896901-
OPPOSITION- Buronfosse-Roque Florence, Fanny Bellebeau-Barbier, Xavier Pineau, Stéphane Queffélec, "Propriétés pharmacologiques et toxicologiques des antiparasitaires externes", Le Point Vétérinaire, (20170401), no. 374, XP055896040-
OPPOSITION- "Macrocyclic lactones in antiparasitic therapy", CABI, (20020000), page 432-
OPPOSITION- McCall, J.W., "The safety-net story about macrocyclic lactone heartworm preventives: A review, an update, and recommendations", Veterinary Parasitology, ELSEVIER SCIENCE, AMSTERDAM., NL, NL , (20051024), vol. 133, no. 2-3, ISSN 0304-4017, pages 197 - 206, XP027655651-
OPPOSITION- Nadege Chailleux, Manon Paradis, "Efficacy of selamectin in the treatment of naturally acquired cheyletiellosis in cats", Can. Vet. J., (20021001), vol. 43, no. 10, pages 767 - 770, XP055762857-
OPPOSITION- Nadege Chailleux, Manon Paradis, "Efficacy of selamectin in the treatment of naturally acquired cheyletiellosis in cats", Can. Vet. J., (20021001), vol. 43, pages 767 - 770, XP055762857-
OPPOSITION- Vercruysse J., "Macrocyclic lactones in antiparasitic therapy", ACADEMIA, (20020000), pages 1 - 447-
OPPOSITION- Wall Richard, Shearer David, "Veterinary Ectoparasites: Biology, Pathology and Control", BLACKWELL SCIENCE, (20010601), pages 1 - 275, XP055948851-
OPPOSITION- Ozoe, Y. ; Asahi, M. ; Ozoe, F. ; Nakahira, K. ; Mita, T., "The antiparasitic isoxazoline A1443 is a potent blocker of insect ligand-gated chloride channels", Biochemical and Biophysical Research Communications, Elsevier, Amsterdam NL, Amsterdam NL , (20100101), vol. 391, no. 1, doi:10.1016/j.bbrc.2009.11.131, ISSN 0006-291X, pages 744 - 749, XP026823770
OPPOSITION- Ozoe, Y. ; Asahi, M. ; Ozoe, F. ; Nakahira, K. ; Mita, T., "The antiparasitic isoxazoline A1443 is a potent blocker of insect ligand-gated chloride channels", Biochemical and Biophysical Research Communications, Elsevier, Amsterdam NL, Amsterdam NL , (20100101), vol. 391, no. 1, doi:10.1016/j.bbrc.2009.11.131, ISSN 0006-291X, pages 744 - 749, XP026907975

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents